NEW YORK, Sept. 27, 2022 /PRNewswire/ — One of the key trends in the degenerative disc disease market is the launch of innovative products. Technologically advanced products are more effective in treating DDD when compared to other treatments. For instance, in May 2020, DePuy Synthes announced the launch of the CONCORDE LIFT Interbody Implant. The device was designed to help treat DDD patients. It can simplify important stages of spinal fusion surgery, which will help restore spinal disc height between two vertebrae. Thus, the launch of innovative and technologically advanced products will support the growth of the market during the forecast period.
The degenerative disc disease market size is expected to grow by USD 1.03 billion from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 8.51% during the forecast period, according to Technavio.
Get a comprehensive report summary describing the market size and forecast along with research methodology. The FREE sample report is available in PDF format
Degenerative Disc Disease Market: Product Landscape
By product, the market has been segmented into drugs and devices. The drugs segment will be the largest contributor to market growth during the forecast period. This growth is attributed to factors such as the increasing incidence of DDD among the geriatric population. Spinal disc degeneration is prevalent among the elderly population. About 70% to 80% of people under the age of 50 and more than 90% of people over the age of 60 have degenerative disc disease. Initially, DDD is treated conservatively with nonsteroidal anti-inflammatory drugs (NSAIDs) and over-the-counter or prescription drugs.
Degenerative Disc Disease Market: Geographic Landscape
By geography, the market has been segmented into North America, Europe, Asia, and Rest of World (ROW). North America is expected to have lucrative growth during the forecast period. About 42% of the market’s overall growth is expected to originate from the region. The US is a key country in the degenerative disc disease market in North America. The growth of this region is attributed to factors such as the rising geriatric population. According to the World Bank Group (WBG), the population aged 65 and above (% of the total population) in the US reached 17% in 2021 from 13% in 2000.
Companies Covered
- AnGes Inc.
- Ankasa
- B. Braun SE
- BIOPHARM GmbH
- BioRestorative Therapies Inc.
- Biosplice Therapeutics Inc.
- Bone Therapeutics SA
- CalSpine MD
- Cousin Biotech
- DiscGenics Inc.
- Globus Medical Inc.
- Johnson and Johnson
- Medtronic Plc
- Pfizer Inc.
- RTI Surgical Inc.
- Smith and Nephew plc
- Ulrich Medical USA Inc.
- Zimmer Biomet Holdings Inc.
Technavio’s reports provide key strategic initiatives used by vendors, along with key news and the latest developments. View our FREE PDF Sample Report Now
What our reports offer
- Market share calculations for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers market data for 2020, 2021, until 2025
- Market trends (opportunities, drivers, threats, challenges, recommendations, and investment opportunities)
- Strategic recommendations in key business segments according to market estimates
- Competitive landscaping recording the key common trends
- Company profiling with financials, detailed strategies, and recent developments
- Supply chain trends mapping the latest technological advances
Related Reports
Women’s Health Therapeutics Market by Type and Geography – Forecast and Analysis 2022-2026: The women’s health therapeutics market share is expected to increase by USD 30.35 billion from 2021 to 2026.
Mental Health Market by Service and Geography – Forecast and Analysis 2022-2026: The mental health market share is expected to increase by USD 201.41 billion from 2021 to 2026.
| Degenerative Disc Disease Market Scope | |
| Report Coverage | Details |
| Page number | 120 |
| Base year | 2021 |
| Forecast period | 2022-2026 |
| Growth momentum & CAGR | Accelerate at a CAGR of 8.51% |
| Market growth 2022-2026 | USD 1.03 billion |
| Market structure | Fragmented |
| YoY growth (%) | 8.0 |
| Regional analysis | North America, Europe, Asia, and Rest of World (ROW) |
| Performing market contribution | North America at 42% |
| Key consumer countries | US, Germany, UK, China, and Japan |
| Competitive landscape | Leading companies, competitive strategies, consumer engagement scope |
| Companies profiled | AnGes Inc., Ankasa, B. Braun SE, BIOPHARM GmbH, BioRestorative Therapies Inc., Biosplice Therapeutics Inc., Bone Therapeutics SA, CalSpine MD, Cousin Biotech, DiscGenics Inc., Globus Medical Inc., Johnson and Johnson, Medtronic Plc, Pfizer Inc., RTI Surgical Inc., Smith and Nephew plc, Ulrich Medical USA Inc., and Zimmer Biomet Holdings Inc. |
| Market Dynamics | Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID -19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
| Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse Health Care Market Reports
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
5 Market Segmentation by Product
- 5.1 Market segments
- Exhibit 24: Chart on Product – Market share 2021-2026 (%)
- Exhibit 25: Data Table on Product – Market share 2021-2026 (%)
- 5.2 Comparison by Product
- Exhibit 26: Chart on Comparison by Product
- Exhibit 27: Data Table on Comparison by Product
- 5.3 Drugs – Market size and forecast 2021-2026
- Exhibit 28: Chart on Drugs – Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Drugs – Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Drugs – Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Drugs – Year-over-year growth 2021-2026 (%)
- 5.4 Devices – Market size and forecast 2021-2026
- Exhibit 32: Chart on Devices – Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Devices – Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Devices – Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Devices – Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Product
- Exhibit 36: Market opportunity by Product ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America – Market size and forecast 2021-2026
- Exhibit 42: Chart on North America – Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America – Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America – Year-over-year growth 2021-2026 (%)
- 7.4 Europe – Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe – Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe – Year-over-year growth 2021-2026 (%)
- 7.5 Asia – Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia – Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia – Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia – Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
- 7.7 US – Market size and forecast 2021-2026
- Exhibit 58: Chart on US – Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US – Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US – Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US – Year-over-year growth 2021-2026 (%)
- 7.8 Germany – Market size and forecast 2021-2026
- Exhibit 62: Chart on Germany – Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Germany – Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Germany – Year-over-year growth 2021-2026 (%)
- 7.9 UK – Market size and forecast 2021-2026
- Exhibit 66: Chart on UK – Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on UK – Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on UK – Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on UK – Year-over-year growth 2021-2026 (%)
- 7.10 China – Market size and forecast 2021-2026
- Exhibit 70: Chart on China – Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on China – Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on China – Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on China – Year-over-year growth 2021-2026 (%)
- 7.11 Japan – Market size and forecast 2021-2026
- Exhibit 74: Chart on Japan – Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Japan – Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Japan – Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 B. Braun SE
- Exhibit 85: B. Braun SE – Overview
- Exhibit 86: B. Braun SE – Business segments
- Exhibit 87: B. Braun SE – Key news
- Exhibit 88: B. Braun SE – Key offerings
- Exhibit 89: B. Braun SE – Segment focus
- 10.4 CalSpine MD
- Exhibit 90: CalSpine MD – Overview
- Exhibit 91: CalSpine MD – Product / Service
- Exhibit 92: CalSpine MD – Key offerings
- 10.5 Cousin Biotech
- Exhibit 93: Cousin Biotech – Overview
- Exhibit 94: Cousin Biotech – Product / Service
- Exhibit 95: Cousin Biotech – Key offerings
- 10.6 DiscGenics Inc.
- Exhibit 96: DiscGenics Inc. – Overview
- Exhibit 97: DiscGenics Inc. – Product / Service
- Exhibit 98: DiscGenics Inc. – Key offerings
- 10.7 Globus Medical Inc.
- Exhibit 99: Globus Medical Inc. – Overview
- Exhibit 100: Globus Medical Inc. – Product / Service
- Exhibit 101: Globus Medical Inc. – Key offerings
- 10.8 Johnson and Johnson
- Exhibit 102: Johnson and Johnson – Overview
- Exhibit 103: Johnson and Johnson – Business segments
- Exhibit 104: Johnson and Johnson – Key news
- Exhibit 105: Johnson and Johnson – Key offerings
- Exhibit 106: Johnson and Johnson – Segment focus
- 10.9 Medtronic Plc
- Exhibit 107: Medtronic Plc – Overview
- Exhibit 108: Medtronic Plc – Business segments
- Exhibit 109: Medtronic Plc – Key news
- Exhibit 110: Medtronic Plc – Key offerings
- Exhibit 111: Medtronic Plc – Segment focus
- 10.10 RTI Surgical Inc.
- Exhibit 112: RTI Surgical Inc. – Overview
- Exhibit 113: RTI Surgical Inc. – Product / Service
- Exhibit 114: RTI Surgical Inc. – Key offerings
- 10.11 Ulrich Medical USA Inc.
- Exhibit 115: Ulrich Medical USA Inc. – Overview
- Exhibit 116: Ulrich Medical USA Inc. – Product / Service
- Exhibit 117: Ulrich Medical USA Inc. – Key offerings
- 10.12 Zimmer Biomet Holdings Inc.
- Exhibit 118: Zimmer Biomet Holdings Inc. – Overview
- Exhibit 119: Zimmer Biomet Holdings Inc. – Business segments
- Exhibit 120: Zimmer Biomet Holdings Inc. – Key news
- Exhibit 121: Zimmer Biomet Holdings Inc. – Key offerings
- Exhibit 122: Zimmer Biomet Holdings Inc. – Segment focus
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 123: Inclusions checklist
- Exhibit 124: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 125: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 126: Research methodology
- Exhibit 127: Validation techniques employed for market sizing
- Exhibit 128: Information sources
- 11.5 List of abbreviations
- Exhibit 129: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
SOURCE Technavio
